- 2016
- List its shares on the New Third Board, the over-the-counter (OTC) stock exchange in china, stock code:837709.
- Registered capital of Seebio was increased to RMB 19,500,000.
- Seebio launched its B2C website www.allinno.com.
- 2011
- Registered capital of Seebio was increased to RMB 12,180,000.
- 2010
- Seebio upgraded its ERP and CRM.
- 2009
- Seebio launched its B2C website www.seebio.cn.
- Facing a global economic crisis, Seebio calmly dealt with an opposite blooming.
- A R&D platform of new medicine, healthcare products and biotechnique, mainly composed of Shanghai Shangela Pharm Science and Technologies Co., Ltd., was established, which set up a stragetic cooperative relationship with the Academy of Drugs in Shanghai Jiao Tong Univerisity.
- 2007
- The biological portal, www.cnbio.net, opened to the public.
- 2006.6
- Shanghai Seebio Biotech, Inc. moved into Shanghai 1st Center on Bisheng Road.
- A R&D and production joint-venture of vitamin K and tranditional Chinese medicine monomer was established in Yunnan.
- The registration of the trademarks, “ Canmedo” and “康美多”, in healthcare products was granted.
- 2005.5
- The registration of the trademarks, “Seebio”and “西宝”, in life science products was granted.
- 2003.6
- Shanghai Seebio Biotech, Inc. was registered in Zhangjiang Hi-Tech Park.
- 2002
- The first website of our company, www.cxbio.com, opened to the public.
- 1999.9
- The foundation of Xiamen API INC. was witnessed by the world.